Engineered cytokine derivatives for targeted cancer immunotherapy

Download
Abstract (PDF, 116.0Kb)
Fulltext (PDF, 5.422Mb)
Thumbnail
Open access
Author
Venetz, Dario
Date
2016
Type
    Doctoral Thesis
Rights / license
In Copyright - Non-Commercial Use Permitted
Permanent link
https://doi.org/10.3929/ethz-a-010792885
Publication status
published
External links
Search print copy at ETH Library
Contributors
Examiner: Neri, Dariocc
Examiner: Halin, Cornelia
Publisher
ETH Zürich
Subject
KREBSTHERAPIE + TUMORTHERAPIE (MEDIZIN); IMMUNPHARMAKOLOGIE + IMMUNTHERAPIE + IMMUNPROPHYLAXE + IMMUNOLOGISCHE PRÄPARATE; ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); ZYTOKINE (IMMUNOLOGIE); MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN); INTERLEUKIN-12 (IMMUNOLOGIE); ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG; CANCER TREATMENT + TUMOUR TREATMENT (MEDICINE); IMMUNOTHERAPY + IMMUNOPHARMACOLOGY + IMMUNOLOGIC MEDICAMENTS + IMMUNOPROPHYLACTIC AGENTS; TARGETED DRUGS (PHARMACOLOGY); CYTOKINES (IMMUNOLOGY); MONOCLONAL ANTIBODIES (IMMUNOLOGICAL TECHNIQUES); INTERLEUKIN-12 (IMMUNOLOGY); DRUG DEVELOPMENT + DRUG DESIGN + DRUG DISCOVERY (PHARMACY)
Organisational unit
02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.
Notes
Dissertation. ETH Zürich. 2016. No. 23658.
More
Show all metadata
ETH Bibliography
yes
Altmetrics